Mahsa Borjzadehgashtaseb

Mahsa Borjzadehgashtaseb

Auto-generated profile, based on publicly available information

Mahsa Borjzadehgashtaseb

Department of Cardiology, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Health Science Reports
Verified
Journal Article
Open access
PAPouria Azami
Pouria Azami
AMAlireza Mirhosseini
Alireza Mirhosseini
MNMohammadjavad Nobakhti
Mohammadjavad Nobakhti
MSMehrab Sayadi
Mehrab Sayadi
MKMohammad Keshavarz
Mohammad Keshavarz
AAArmin Attar
Armin Attar
Background and Aims: Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, making early detection and risk assessment critical. Various clinical tools, including the Atherosclerotic Cardiovascular Disease (ASCVD) risk score, have been developed to predict cardiovascular risk. This study aimed to evaluate the association of various Electrocardiogram (ECG) findings with 10‐year ASCVD risk scores in asymptomatic individuals without prior cardiovascular events, using data from the Shiraz Heart Study (SHS). Materials and Methods: This cross‐sectional study included participants aged 40–70 years from the Shiraz Heart Study (SHS). Inclusion criteria required complete ECG data and recorded ASCVD risk factors. ECG findings, encompassing both continuous and categorical variables, were reviewed by trained cardiologists. ASCVD risk scores were calculated using demographic and clinical variables. Statistical analyses, including multivariate regression, assessed associations between ECG parameters and 10‐year ASCVD risk scores, adjusting for key confounders. Result: A total of 1471 participants were included in the study, with 44.5% male ( N = 654) and a mean age of 51.65 years (SD = 7.84). The mean ASCVD score was 5.49 (SD = 6.41). Significant associations were found between continuous ECG variables, such as P‐wave duration, PR interval, QRS duration, and QRS axis, with ASCVD risk. Categorical ECG findings, including ST depression, ST elevation, left bundle branch block (LBBB), prolonged P‐wave duration, and left atrial enlargement, were also significantly associated with ASCVD scores. Multivariate linear regression identified ST depression ( B = 0.060, p < 0.001) and LBBB ( B = 0.031, p = 0.039) as independent predictors of ASCVD risk, after adjusting for confounders such as age, gender, hypertension, diabetes, and cholesterol levels. Conclusion: ST depression and LBBB show a modest association with cardiovascular risk stratification using the 10‐year ASCVD risk score. Incorporating these ECG markers into clinical assessments may aid in identifying high‐risk individuals, enabling more personalized interventions and refining cardiovascular risk prediction models.

1 June 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
DADavar Aledavood
Davar Aledavood
ZAZahra Alizadeh
Zahra Alizadeh
MBMahsa Borjzadehgashtaseb
Mahsa Borjzadehgashtaseb
Background: Coronary embolism is a rare but clinically important non-atherosclerotic cause of acute myocardial infarction. Its diagnosis becomes especially challenging in young patients with mechanical valves, especially when the presentation follows blunt chest trauma. Case summary: A 24-year-old man with a mechanical aortic valve presented with progressive chest pain and dyspnoea 2 days after blunt chest trauma. Electrocardiography (ECG) demonstrated extensive anterior–lateral ST-segment elevation myocardial infarction (STEMI). Transoesophageal echocardiography revealed normal prosthetic valve function, an apical aneurysm, and a non-mobile left ventricular (LV) mural thrombus. Coronary angiography showed a large thrombotic occlusion in the proximal left anterior descending (LAD) artery with otherwise normal coronary anatomy. Findings were most consistent with coronary embolism originating from a trauma-induced LV mural thrombus. Given the high thrombus burden, the patient received dual antiplatelet therapy, continued warfarin, and tirofiban infusion. Follow-up imaging confirmed complete resolution of the thrombus and improvement in ventricular function. Discussion: This case illustrates the rare mechanism of trauma-induced LV mural thrombus embolization causing STEMI in a young prosthetic-valve patient. Integration of multimodality imaging coupled with meticulous clinical reasoning is required for systematic exclusion of spontaneous coronary artery dissection (SCAD), infective endocarditis, prosthetic-valve thrombosis, hypercoagulable states, and in situ coronary thrombosis to establish the true aetiology. Tirofiban may be an effective adjunct in high-burden embolic coronary occlusions when distal flow is preserved.

9 July 2026 in Annals of Thoracic Surgery Short Reports
Verified
Journal Article
Open access
ZAZahra Alizadeh
Zahra Alizadeh
MBMahsa Borjzadehgashtaseb
Mahsa Borjzadehgashtaseb
ARAli Rajabi
Ali Rajabi
SASimin Azemati
Simin Azemati
AAAhmad Ali Amirghofran
Ahmad Ali Amirghofran
AAAmir Askari
Amir Askari

30 July 2026 in Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
MBMahsa Borjzadehgashtaseb
Mahsa Borjzadehgashtaseb
GFGhazal Farahshirazi
Ghazal Farahshirazi
Background: Epidermal inclusion cysts (EICs) are common benign cutaneous lesions; however, their occurrence in the mediastinum is exceedingly rare. Case presentation: We report a 29-year-old woman with a well-circumscribed mediastinal mass detected on imaging. The lesion was excised via video-assisted thoracoscopic surgery. Gross examination revealed a 6 × 5 × 3 cm cystic mass filled with whitish keratinous material. Histopathologic analysis demonstrated a cyst lined by stratified squamous epithelium with a well-developed granular layer and abundant laminated keratin debris. No adnexal structures or cytologic atypia were identified. Conclusion: Primary mediastinal EIC is a rare benign entity that may radiologically simulate other mediastinal cysts. Accurate diagnosis relies on histopathologic evaluation, and complete excision is curative. Awareness of this entity is important to prevent overdiagnosis and ensure appropriate surgical management. This case emphasizes the importance of considering epidermal inclusion cyst in the differential diagnosis of anterior mediastinal cystic lesions to avoid misdiagnosis and unnecessary aggressive management.

19 August 2026 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
PDF file
Shayan ShojaeiShayan Shojaei
Shayan Shojaei
DSDorsa Shekouh
Dorsa Shekouh
AMAsma Mousavi
Asma Mousavi
SRSalma Rostamipourfard
Salma Rostamipourfard
SKSaeed Karami
Saeed Karami
AAAlireza Arzhangzadeh
Alireza Arzhangzadeh
Background: Activation of the renin‐angiotensin‐aldosterone system contributes to hepatic inflammation in metabolic dysfunction‐associated steatotic liver disease (MASLD). Telmisartan, an angiotensin II receptor blocker with partial PPAR‐γ agonistic activity, has been hypothesized to confer metabolic benefits; however, current clinical evidence has not consistently demonstrated such effects. Aim: This systematic review and meta‐analysis evaluated the efficacy of telmisartan on metabolic, biochemical, and histological outcomes in MASLD. Methods: Electronic databases (PubMed, Embase, Web of Science, Scopus) were searched through 2026 for randomized controlled trials (RCTs) investigating telmisartan in adults with MASLD. Risk of bias was assessed using the RoB2 tool. Random‐effects meta‐analyses calculated pooled mean differences (MDs) with 95% confidence intervals (CIs). Results: Six RCTs comprising 258 participants (126 telmisartan, 132 controls) met the inclusion criteria. Telmisartan treatment was associated with a modest reduction in fasting blood sugar compared with controls (MD = −2.78 mg/dL; 95% CI −5.17 to −0.39; p = 0.023); however, this finding was accompanied by substantial heterogeneity (I 2 = 91.8%) and should therefore be interpreted cautiously. No significant changes were observed for body mass index, waist circumference, HOMA‐IR, lipid profiles, ALT, or AST. Conversely, gamma‐glutamyl transferase (GGT) levels showed a modest but significant increase with telmisartan (MD = 5.40 U/L; 95% CI 0.51 to 10.29; p = 0.031). Histological analyses revealed a non‐significant trend toward fibrosis stage improvement (MD = −0.28; 95% CI −0.57 to 0.01; p = 0.060), with no significant improvements seen in the overall NAFLD activity score, steatosis, ballooning, or lobular inflammation. Most included trials carried a low overall risk of bias. Conclusion: Current evidence does not demonstrate consistent metabolic, biochemical, or histological benefits of telmisartan in MASLD. Although a modest reduction in fasting blood glucose was observed, substantial between‐study heterogeneity and the modest effect size limit confidence in this finding.

27 November 2025 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
MZMohammad Javad Zibaeenezhad
Mohammad Javad Zibaeenezhad
ZAZahra Alizadeh
Zahra Alizadeh
ARAli Rajabi
Ali Rajabi
MBMahsa Borjzadehgashtaseb
Mahsa Borjzadehgashtaseb
Scorpion envenomation is a significant medical concern in tropical and subtropical regions, with cardiovascular complications being among its most severe m